7th International DOG-Symposium on AMD

The recent revolution in genetic and molecular biological studies as well as imaging and artificial intelligence has contributed significantly to our understanding of AMD. However, many open questions are still to be addressed. We are approaching an era of new targets for therapy based on better differentiation, refined phenotyping and predictive markers of age-related macular disease. Four years after the last international Baden-Baden AMD meeting it appears timely to review emerging concepts. We look forward to welcoming you in Baden-Baden.